Does NEXAVAR Cause Hepatocellular carcinoma? 42 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 42 reports of Hepatocellular carcinoma have been filed in association with NEXAVAR. This represents 11.5% of all adverse event reports for NEXAVAR.
42
Reports of Hepatocellular carcinoma with NEXAVAR
11.5%
of all NEXAVAR reports
33
Deaths
12
Hospitalizations
How Dangerous Is Hepatocellular carcinoma From NEXAVAR?
Of the 42 reports, 33 (78.6%) resulted in death, 12 (28.6%) required hospitalization, and 1 (2.4%) were considered life-threatening.
Is Hepatocellular carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NEXAVAR. However, 42 reports have been filed with the FAERS database.
What Other Side Effects Does NEXAVAR Cause?
Diarrhoea (46)
Palmar-plantar erythrodysaesthesia syndrome (36)
Hepatic cancer (27)
Decreased appetite (24)
Hypertension (22)
Fatigue (20)
Renal cancer (20)
Rash (19)
Abdominal pain (18)
Nausea (18)
What Other Drugs Cause Hepatocellular carcinoma?
SORAFENIB (1,665)
RIBAVIRIN (1,046)
SOFOSBUVIR (877)
LEDIPASVIR\SOFOSBUVIR (640)
BEVACIZUMAB (532)
REGORAFENIB (470)
DACLATASVIR (419)
ATEZOLIZUMAB (342)
CABOZANTINIB S-MALATE (219)
TACROLIMUS (183)
Which NEXAVAR Alternatives Have Lower Hepatocellular carcinoma Risk?
NEXAVAR vs NEXIUM
NEXAVAR vs NEXPLANON
NEXAVAR vs NIACIN
NEXAVAR vs NIACINAMIDE
NEXAVAR vs NICARDIPINE